Aethlon Medical Inc (AEMD) - Total Assets
Based on the latest financial reports, Aethlon Medical Inc (AEMD) holds total assets worth $8.06 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Aethlon Medical Inc shareholders equity for net asset value and shareholders' equity analysis.
Aethlon Medical Inc - Total Assets Trend (1997–2025)
This chart illustrates how Aethlon Medical Inc's total assets have evolved over time, based on quarterly financial data.
Aethlon Medical Inc - Asset Composition Analysis
Current Asset Composition (March 2025)
Aethlon Medical Inc's total assets of $8.06 Billion consist of 80.8% current assets and 19.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 74.8% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $550.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1997–2025)
This chart illustrates how Aethlon Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Aethlon Medical Inc stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aethlon Medical Inc's current assets represent 80.8% of total assets in 2025, a decrease from 91.2% in 1997.
- Cash Position: Cash and equivalents constituted 74.8% of total assets in 2025, down from 91.2% in 1997.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1997.
- Asset Diversification: The largest asset category is intangible assets at 0.0% of total assets.
Aethlon Medical Inc Competitors by Total Assets
Key competitors of Aethlon Medical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.15 Billion |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607
|
China | CN¥988.48 Million |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
|
USA | $139.92 Million |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO
|
India | Rs8.57 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
|
Aligned Genetics Inc
KQ:238120
|
Korea | ₩45.11 Billion |
|
Heramed Ltd
AU:HMD
|
Australia | AU$1.04 Million |
|
Acarix A/S
ST:ACARIX
|
Sweden | Skr48.33 Million |
Aethlon Medical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.68 | 2.80 | 7.53 |
| Quick Ratio | 5.68 | 2.80 | 7.53 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $5.88 Billion | $3.19 Million | $8.98 Million |
Aethlon Medical Inc - Advanced Valuation Insights
This section examines the relationship between Aethlon Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.33 |
| Latest Market Cap to Assets Ratio | 0.38 |
| Asset Growth Rate (YoY) | -10.8% |
| Total Assets | $7.36 Million |
| Market Capitalization | $2.79 Million USD |
Valuation Analysis
Below Book Valuation: The market values Aethlon Medical Inc's assets below their book value (0.38x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Aethlon Medical Inc's assets decreased by 10.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Aethlon Medical Inc (1997–2025)
The table below shows the annual total assets of Aethlon Medical Inc from 1997 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | $7.36 Million | -10.75% |
| 2024-03-31 | $8.25 Million | -52.90% |
| 2023-03-31 | $17.51 Million | -9.83% |
| 2022-03-31 | $19.42 Million | +82.00% |
| 2021-03-31 | $10.67 Million | +2.71% |
| 2020-03-31 | $10.39 Million | +151.95% |
| 2019-03-31 | $4.12 Million | -43.92% |
| 2018-03-31 | $7.35 Million | +325.86% |
| 2017-03-31 | $1.73 Million | -32.48% |
| 2016-03-31 | $2.56 Million | +85.19% |
| 2015-03-31 | $1.38 Million | -18.55% |
| 2014-03-31 | $1.70 Million | +241.28% |
| 2013-03-31 | $496.69K | -40.78% |
| 2012-03-31 | $838.69K | +47.86% |
| 2011-03-31 | $567.22K | -12.20% |
| 2010-03-31 | $646.00K | +227.27% |
| 2009-03-31 | $197.39K | -59.56% |
| 2008-03-31 | $488.11K | -20.42% |
| 2007-03-31 | $613.36K | -40.44% |
| 2006-03-31 | $1.03 Million | +242.86% |
| 2005-03-31 | $300.35K | +6.64% |
| 2004-03-31 | $281.66K | -29.32% |
| 2003-03-31 | $398.52K | -59.06% |
| 2002-03-31 | $973.54K | -24.18% |
| 2001-03-31 | $1.28 Million | -2.73% |
| 2000-03-31 | $1.32 Million | +1508.33% |
| 1999-03-31 | $82.07K | +10785.01% |
| 1998-03-31 | $754.00 | -72.32% |
| 1997-03-31 | $2.72K | -- |
About Aethlon Medical Inc
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Di… Read more